319
Views
0
CrossRef citations to date
0
Altmetric
Influenza

Characteristics and factors of repeated influenza vaccination among elderly individuals in Shanghai, China from 2020 to 2022

, , , , & ORCID Icon
Article: 2364480 | Received 08 Feb 2024, Accepted 31 May 2024, Published online: 07 Jul 2024

References

  • Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–6. doi:10.1016/S0140-6736(17)33293-2.
  • Langer J, Welch VL, Moran MM, Cane A, Lopez SMC, Srivastava A, Enstone AL, Sears A, Markus KJ, Heuser M, et al. High clinical burden of influenza disease in adults aged ≥ 65 years: can we do better? A systematic literature review. Adv Ther. 2023;40(4):1601–27. doi:10.1007/s12325-023-02432-1.
  • Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, Wong JYT, Yang J, Bond HS, Wang L, et al. Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study. Lancet Public Health. 2019;4(9):473–81. doi:10.1016/S2468-2667(19)30163-X.
  • National Health Commission of the People’s Republic of China. Interpretation Q&A of “opinions of the communist party of China central committee and the state council on strengthening the work for the elderly in the new era”. 2021 Nov 24 [accessed 2024 Feb 5]. http://www.nhc.gov.cn/lljks/pqt/202111/d51065f1cfea4106870ff9e367dc5eee.shtml.
  • World Health Organization. Vaccines against influenza: WHO position paper – May 2022. Wkly Epidemiol Rec. 2022;97(19):185–208.
  • National Immunization Advisory Committee (NIAC), Technical Working Group (TWG). Influenza Vaccination TWG. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)]. Zhonghua Liu Xing Bing Xue Za Zhi. 2023;44(10):1507–30. doi:10.3760/cma.j.cn112338-20230908-00139.
  • Mordant FL, Price OH, Rudraraju R, Slavin MA, Marshall C, Worth LJ, Peck H, Barr IG, Sullivan SG, Subbarao K. Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post-vaccination but persist for at least 6 months. Influenza Other Respir Viruses. 2023;17(1):e13072. doi:10.1111/irv.13072.
  • Frasca D, Blomberg BB. Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination. Immun Ageing. 2020;17(1):37. doi:10.1186/s12979-020-00210-z.
  • Mulla RT, Turcotte LA, Wellens NI, Angevaare MJ, Weir J, Jantzi M, Hébert PC, Heckman GA, van Hout H, Millar N, et al. Prevalence and predictors of influenza vaccination in long-term care homes: a cross-national retrospective observational study. BMJ Open. 2022;12(4):e057517. doi:10.1136/bmjopen-2021-057517.
  • Hou Z, Guo J, Lai X, Zhang H, Wang J, Hu S, Du F, Francis MR, Fang H. Influenza vaccination hesitancy and its determinants among elderly in China: a national cross-sectional study. Vaccine. 2022;40(33):4806–15. doi:10.1016/j.vaccine.2022.06.063.
  • Stacey HD, Miller MS. Repeated seasonal influenza vaccination: how much is too much of a good thing? J Infect Dis. 2020;222(2):173–5. doi:10.1093/infdis/jiz434.
  • Jones-Gray E, Robinson EJ, Kucharski AJ, Fox A, Sullivan SG. Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis. Lancet Respir Med. 2023;11(1):27–44. doi:10.1016/S2213-2600(22)00266-1.
  • Bardenheier BH, Zullo AR, Jutkowitz E, Gravenstein S. Characteristics of repeated influenza vaccination among older U.S. Adults. Am J Prev Med. 2020;59(5):179–88. doi:10.1016/j.amepre.2020.05.009.
  • Dugord C, Franc C. Trajectories and individual determinants of repeated seasonal flu vaccination use over the long term using data from the French E3N cohort. Vaccine. 2022;40(34):5030–43. doi:10.1016/j.vaccine.2022.07.004.
  • Storch J, Meissner F, Böde M, Kwetkat A, Pletz MW, Freytag A. [Once vaccinated, always vaccinated? A claims data analysis on repeated influenza vaccinations among individuals aged ≥ 60 years]. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2023;66(9):953–61. doi:10.1007/s00103-023-03716-1.
  • Kunasekaran M, Poulos CJ, Chughtai AA, Heslop DJ, MacIntyre CR. Factors associated with repeated influenza vaccine uptake among aged care staff in an Australian sample from 2017 to 2019. Vaccine. 2022;40(50):7238–46. doi:10.1016/j.vaccine.2022.08.015.
  • Zhao HT, Peng ZB, Ni ZL, Yang XK, Guo QY, Zheng JD, Qin Y, Zhang YP. Investigation on influenza vaccination policy and vaccination situation during the influenza seasons of 2020-2021 and 2021–2022 in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2022;56(11):1560–4. doi:10.3760/cma.j.cn112150-20220810-00802.
  • Shanghai Municipal Bureau of Statistics. Statistical Yearbook. 2024 Feb 5 [accessed 2024 Feb 5]. https://tjj.sh.gov.cn/tjnj/index.html.
  • Nogareda F, Gharpure R, Contreras M, Velandia M, Lucia Pacis C, Elena Chevez A, Azziz-Baumgartner E, Salas D. Seasonal influenza vaccination in the Americas: progress and challenges during the COVID-19 pandemic. Vaccine. 2023;41(31):4554–60. doi:10.1016/j.vaccine.2023.06.024.
  • Zhou Y, Tang J, Zhang J, Wu Q. Impact of the coronavirus disease 2019 epidemic and a free influenza vaccine strategy on the willingness of residents to receive influenza vaccines in Shanghai, China. Hum Vaccin Immunother. 2021;17(7):2289–92. doi:10.1080/21645515.2020.1871571.
  • Principi N, Autore G, Ramundo G, Esposito S. Epidemiology of Respiratory Infections during the COVID-19 Pandemic. Viruses. 2023;15(5):1160. doi:10.3390/v15051160.
  • Lymon H, Meng L, Reses HE, Barbre K, Dubendris H, Shafi S, Wiegand R, Reddy GRTY, Woods A, Kuhar DT, et al. Declines in Influenza Vaccination Coverage Among Health Care Personnel in Acute Care Hospitals During the COVID-19 Pandemic - United States, 2017–2023. MMWR Morb Mortal Wkly Rep. 2023;72(45):1244–7. doi:10.15585/mmwr.mm7245a6.
  • Ma L, Han X, Ma Y, Yang Y, Xu Y, Liu D, Yang W, Feng L. Decreased influenza vaccination coverage among Chinese healthcare workers during the COVID-19 pandemic. Infect Dis Poverty. 2022;11(1):105. doi:10.1186/s40249-022-01029-0.
  • Nitzan I, Akavian I, Adar O, Rittblat M, Tomer G, Shmueli O, Friedensohn L, Talmy T. Acceptance of Seasonal Influenza Vaccine Following COVID-19 Vaccination: A Survey among Israel Defense Forces Soldiers. Behav Med. 2022;50(2):98–105. doi:10.1080/08964289.2022.2119361.
  • Liang X, Li J, Fang Y, Zhang Q, Wong MCS, Yu FY, Ye D, Chan PS, Kawuki J, Chen S, et al. Associations between COVID-19 Vaccination and Behavioural Intention to Receive Seasonal Influenza Vaccination among Chinese Older Adults: A Population-Based Random Telephone Survey. Vaccines (Basel). 2023;11(7):1213. doi:10.3390/vaccines11071213.
  • Mohamad RMA, Abu Jamileh KI, Ali MRA, Makki KHA, Alshehri WA, Fadul SSA, Buraei SSEM, Al-Lahim WAS, Abosalamh HAA, Althobaiti ASH, et al. Acceptability of The Flu Vaccine among The General Population in Tabuk, Saudi Arabia, 2021–2022. Egypt J Hosp Med. 2023;90(1):610–20. doi:10.21608/ejhm.2023.279815.
  • Tan HY, Lai E, Kunasekaran M, Chughtai AA, Trent M, Poulos CJ, MacIntyre CR. Prevalence and predictors of influenza vaccination among residents of long-term care facilities. Vaccine. 2019;37(43):6329–35. doi:10.1016/j.vaccine.2019.09.021.
  • Sulis G, Basta NE, Wolfson C, Kirkland SA, McMillan J, Griffith LE, Raina P. Canadian longitudinal study on aging (CLSA) team. Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: an analysis of the Canadian Longitudinal study on Aging (CLSA). Vaccine. 2022;40(3):503–11. doi:10.1016/j.vaccine.2021.11.088.
  • Sinilaite A, Young K, Papenburg J. Summary of the National Advisory Committee on Immunization (NACI) statement-recommendation on repeated seasonal influenza vaccination. Can Commun Dis Rep. 2023;49(4):99–102. doi:10.14745/ccdr.v49i04a02.
  • Ren MR, Li KL, Li Y, Fan CX, Li Y, Zhang LN, Song YF, Cao L, Yu WZ, Yin ZD. [Surveillance for adverse events following immunization with influenza vaccine in China during the 2018–2019 and 2019–2020 influenza seasons]. Zhongguo Yi Miao He Mian Yi. 2023;29(2):197–203. doi:10.19914/j.CJVI.2023034.
  • Amicizia D, Domnich A, Lai PL, Orsi A, Icardi G, Tkach-Motulyak O, Panatto D. Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season. Hum Vaccin Immunother. 2023;19(1):2190279. doi:10.1080/21645515.2023.2190279.
  • Pillsbury AJ, Fathima P, Quinn HE, Cashman P, Blyth CC, Leeb A, Macartney KK. Comparative postmarket safety profile of adjuvanted and high-dose influenza vaccines in individuals 65 years or older. JAMA Netw Open. 2020;3(5):e204079. doi:10.1001/jamanetworkopen.2020.4079.